Table 2. Clinical and hormonal parameters of the study population.
| Parameters | Type 2 Diabetics (n = 150) | Healthy controls (n = 150) | 95% CI | P value |
|---|---|---|---|---|
| Age (yrs) | 58.25±9.71 | 56.34±9.40 | -0.258–4.084 | 0.084 |
| BMI (Kg/m2) | 23.05±4.04 | 24.01±3.38 | -1.810-(-0.118) | 0.026* |
| SBP (mmHg) | 145.76±24.77 | 134.94±25.36 | 5.124–16.516 | <0.001* |
| DBP (mmHg) | 86.74±12.91 | 82.15±9.01 | 2.047–7.126 | <0.001* |
| FBS (mmol/L) | 10.33±5.57 | 5.84±0.61 | 3.588–5.394 | <0.001* |
| HbA1C (%) | 8.06±2.58 | 4.78±0.59 | 2.854–3.707 | <0.001* |
| FSH (mIu/ml) | 7.19±4.68 | 8.85±5.05 | -2.767-(-0.555) | 0.003* |
| LH (mIu/ml) | 6.18±3.58 | 7.08±3.90 | -1.642-(-0.162) | 0.017* |
| Testosterone (nmol/l) | 7.66±5.45 | 13.01±7.85 | -6.887-(-3.818) | <0.001* |
(Mean± SD): Body Mass Index (BMI), Diastolic Blood Pressure (DBP), Systolic Blood Pressure (SBP), Fasting Blood Sugar (FBS), Follicle Stimulating Hormones (FSH), Luteinizing Hormone (LH) and * mean difference is significant (p<0.05).